Motherisk update: Multivitamin supplements for pregnant women

Canadian Family Physician

Volumn 50, Issue MAY, 2004, Pages 705-706

  Ahn, Eric ^d   Nava Ocampo, Alejandro A ^a   Koren, Gideon ^a,b,c  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b Motherisk Program   (Canada)

^c CANADIAN INSTITUTES OF HEALTH RESEARCH   (Canada)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CAPTOPRIL; CARBAMAZEPINE; CARBIDOPA; CIPROFLOXACIN; DOXYCYCLINE; FOLIC ACID; FOLIC ACID ANTAGONIST; IRON; LEVODOPA; LEVOTHYROXINE; METACYCLINE; METHYLDOPA; MULTIVITAMIN; OXYTETRACYCLINE; PENICILLAMINE; PREGVIT; SULFONAMIDE; TETRACYCLINE; TETRACYCLINE DERIVATIVE; VALPROIC ACID; VITAMIN;

ABDOMINAL DISCOMFORT; ARTICLE; CASE REPORT; COMPLEX FORMATION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG DOSE REGIMEN; DRUG USE; EPILEPSY; EXPERIENCE; FAMILY HISTORY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; IRON INTAKE; NEURAL TUBE DEFECT; PERNICIOUS ANEMIA; PREGNANCY; RISK ASSESSMENT; VITAMIN SUPPLEMENTATION; ABDOMINAL PAIN; CHEMICALLY INDUCED DISORDER; FEMALE; PRENATAL CARE;

ABDOMINAL PAIN; FEMALE; HUMANS; IRON; PREGNANCY; PRENATAL CARE; VITAMINS;

EID: 2442717535     PISSN: 0008350X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Beaton GH. Iron needs during pregnancy: do we need to rethink our targets? Am J Clin Nutr 2000;72(Suppl 1):265-71S.
2. MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 1991;338:131-7.
3. Czeizel AE, Dudas I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 1992;327:1832-5.
4. Koren G, Boskovic R, Hard M, Maltepe C, Navioz Y, Einarson A. Motherisk-PUQE (pregnancy-unique quantification of emesis and nausea) scoring system for nausea and vomiting of pregnancy. Am J Obstet Gynecol 2002;186(Suppl 5):S228-31.
5. Bendich A. Calcium supplementation and iron status of females. Nutrition 2001;17:46-51.
6. Zijp IM, Korver O, Tijburg LB. Effect of tea and other dietary factors on iron absorption. Crit Rev Food Sci Nutr 2000;40:371-98.
7. Kapur B, Soldin OP, Koren G. Potential prevention of neural tube defects by assessment of women of childbearing age through monitoring of folate. Ther Drug Monit 2002;24:628-30.
8. French AE, Grant R, Weitzman S, Ray JG, Vermeulen MJ, Sung L, et al. Folic acid food fortification is associated with a decline in neuroblastoma. Clin Pharmacol Ther 2003;74:288-94.
9. Wald NJ, Law MR, Morris JK, Wald DS. Quantifying the effect of folic acid. Lancet 2001;358:2069-73.
10. Campbell NR, Hasinoff BB, Stalts H, Rao B, Wong NC. Ferrous sulfate reduces thyroxine efficacy in patients with hypothyroidism. Ann Intern Med 1992;117:1010-3.
11. Singh N, Singh PN, Hershman JM. Effect of calcium carbonate on the absorption of levothyroxine. JAMA 2000;283:2822-5.
12. Chopra IJ, Baber K. Treatment of primary hypothyroidism during pregnancy: is there an increase in thyroxine dose requirement in pregnancy? Metabolism 2003;52:122-8.
13. Campbell NR, Hasinoff BB. Iron supplements: a common cause of drug interactions. Br J Clin Pharmacol 1991;31:251-5.